Surrey Heartlands

Joint Formulary & PAD

Cyclopentolate hydrochloride - Painful Ciliary Spasm

You are here : Home > Formulary Search > Cyclopentolate hydrochloride - Painful Ciliary Spasm

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Eye drops 0.5%, 1%. Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Cyclopentolate hydrochloride
Indication :
Painful Ciliary Spasm
Group Name :
Keywords :
Brand Names Include :
Minims
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Cyclopentolate hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Painful Ciliary Spasm.

Committee Recommendations (1)

05 Sep 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of cyclopentolate eye drops (0.5% & 1%) for the treatment of painful ciliary spasm in blind eyes

Cyclopentolate eye drops will be considered to be BLUE (no information sheet) on the traffic light system.

Initiation will be by consultant ophthalmologists and transfer of care can be considered after a minimum of 2 months prescribing by the consultant and once the patient has shown to be benefiting from treatment.